EP4205730A1 — Pharmaceutical composition of single dosage form for treating or preventing hypertension and hyperlipidemia
Assigned to Daewoong Pharmaceutical Co Ltd · Expires 2023-07-05 · 3y expired
What this patent protects
The present invention provides a single dosage form of pharmaceutical composition for treatment of hypertension and hyperlipidemia. According to the present invention, stability and uniform dissolution rates of drugs may be ensured by mixing compositions containing desired drugs …
USPTO Abstract
The present invention provides a single dosage form of pharmaceutical composition for treatment of hypertension and hyperlipidemia. According to the present invention, stability and uniform dissolution rates of drugs may be ensured by mixing compositions containing desired drugs and formulating the mixture into a single compartment form, whereby a manufacturing process becomes simple while reducing processing costs. Further, a formulation having biological equivalence to conventional single formulations may be obtained.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.